Erythema
Information
- Disease name
- Erythema
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02411656 | Active, not recruiting | Phase 2 | Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy | June 11, 2015 | December 31, 2028 |
NCT02876107 | Active, not recruiting | Phase 2 | Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer | October 6, 2016 | October 31, 2025 |
NCT00839462 | Completed | Phase 2 | Efficacy of Dexpanthenol in Thermic Erythema | September 2007 | September 2007 |
NCT00940446 | Completed | N/A | A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement | July 2007 | April 30, 2010 |
NCT01124513 | Completed | N/A | Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI | May 2010 | December 2010 |
NCT01301677 | Completed | Phase 1 | Ultra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate Hydrocortisone | January 2011 | June 2011 |
NCT01579084 | Completed | Phase 1 | Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea | April 2012 | June 2012 |
NCT01587014 | Completed | Safety and Feasibility of Prima-Temp Thermometer Patch | February 2012 | December 2012 | |
NCT01636765 | Completed | Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale | May 2012 | July 2012 | |
NCT01659853 | Completed | Phase 3 | Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea | September 2012 | December 2012 |
NCT01735201 | Completed | Phase 2 | AGN-199201 for the Treatment of Erythema With Rosacea | December 2012 | June 2013 |
NCT06369727 | Completed | Phase 1 | Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design | October 15, 2017 | February 15, 2018 |
NCT00685438 | Completed | Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude | April 2007 | June 2007 | |
NCT03852563 | Completed | N/A | A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering | March 18, 2019 | April 22, 2019 |
NCT03853538 | Completed | Phase 4 | A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering | January 28, 2019 | March 6, 2019 |
NCT04498676 | Completed | N/A | 50 Human Subject Repeat Insult Patch Test | January 18, 2017 | March 2, 2017 |
NCT04510675 | Completed | N/A | Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT | December 2, 2019 | January 11, 2020 |
NCT04512274 | Completed | N/A | Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin | June 1, 2020 | June 5, 2020 |
NCT05300542 | Completed | N/A | Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema | March 17, 2022 | April 13, 2022 |
NCT05704114 | Completed | Phase 4 | Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne | February 1, 2021 | May 1, 2022 |
NCT06369675 | Completed | Phase 1 | Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design | October 19, 2017 | November 14, 2017 |
NCT01885000 | Completed | Phase 3 | Patient-Reported Outcome Of Facial Erythema (PROOF) | July 1, 2013 | November 14, 2013 |
NCT01976637 | Completed | N/A | Compression Treatment of Superficial Vein Thrombosis | December 2009 | November 2013 |
NCT02095158 | Completed | Phase 3 | A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea | April 2014 | September 2015 |
NCT02131636 | Completed | Phase 3 | Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea | May 2014 | December 2014 |
NCT02132117 | Completed | Phase 3 | Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea | June 2014 | May 2015 |
NCT02297841 | Completed | N/A | Repeated Insult Patch Test of Personal Lubricants | November 2014 | December 2014 |
NCT02320214 | Completed | N/A | A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects | December 2014 | January 2015 |
NCT02320227 | Completed | N/A | A Single-Center, Clinical Study to Evaluate the Safety of a Non-Fragranced Personal Lubricant in Healthy Female Subjects | December 2014 | January 2015 |
NCT02490943 | Completed | N/A | A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS | June 2015 | April 30, 2019 |
NCT02737592 | Completed | N/A | A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects | March 2016 | April 2016 |
NCT02737631 | Completed | N/A | Human Repeat Insult Patch Test to Evaluate Personal Lubricants | February 2016 | March 2016 |
NCT02737852 | Completed | N/A | A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects | March 2016 | May 2016 |
NCT02832141 | Completed | Effect of Thoracic Spine Mobilization on Sympathetic Nervous Systems | May 2016 | December 31, 2018 | |
NCT03041064 | Completed | N/A | Multiday Beach Study | May 27, 2016 | June 1, 2016 |
NCT03352323 | Completed | Phase 3 | An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea | October 18, 2017 | March 30, 2018 |
NCT03477825 | Completed | N/A | Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin | March 12, 2018 | January 25, 2019 |
NCT03530787 | Completed | N/A | Cosmetic Effects of Topical Acetyl Zingerone | December 11, 2017 | October 12, 2018 |
NCT03549429 | Completed | N/A | Tegaderm vs. EyeGard for Eye Protection | June 1, 2018 | July 20, 2018 |
NCT03633877 | Completed | N/A | Durapore vs. Hy-Tape to Secure The Endotracheal Tube | September 17, 2018 | October 11, 2019 |
NCT05742347 | Enrolling by invitation | N/A | Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions | July 1, 2022 | June 9, 2025 |
NCT06016361 | Not yet recruiting | N/A | Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy | September 18, 2023 | March 18, 2024 |
NCT01597921 | Terminated | A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer | May 2012 | December 2012 | |
NCT03496584 | Terminated | N/A | Effects of Phytonutrients on Vascular Health and Skin in Obese Males | March 29, 2018 | February 28, 2021 |
NCT00206921 | Unknown status | N/A | Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness | February 2005 | August 2005 |
NCT00785187 | Unknown status | N/A | Affect of Dose Rate on UVR Induced Skin Erythema | December 2008 | |
NCT04290273 | Withdrawn | N/A | Characterisation of the Time-course Response of UV-induced Erythema | September 2024 | November 2024 |
NCT01882712 | Withdrawn | Phase 3 | Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0010783
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004890